1
Daniel F Herman, Vilambi NRK Reddy: Bonding agent composition containing conductive filler and method of bonding electrode to printed conductive trace with same. Drug Delivery Technologies, Kirkpatrick & Lockhart, May 8, 2001: US06228206 (5 worldwide citation)

The invention relates to a method for using adhesive polymers containing conductive fillers to manufacture iontophoretic devices in which the conductive lead and the conducted printed trace are strongly mechanically bonded together and resulting in electronic interconnection between the conductive l ...


2
Ronald J Flower: Disabling circuit for an iontophoretic system. Drug Delivery Technologies, Kirkpatrick & Lockhart, March 27, 2001: US06208891 (4 worldwide citation)

An apparatus and a corresponding method for the iontophoretic delivery of drugs that operates only when the supply voltage is higher than a predetermined threshold is provided. The apparatus includes a current control circuit for controlling the current in an iontophoretic patch, and a supply voltag ...


3
Burkhard Schlutermann, Manfred Kohlmeyer: Oral preparation with controlled release. ADD Advanced Drug Delivery Technologies, Frommer Lawrence & Haug, April 14, 2015: US09005658

A pharmaceutical pellet is provided, comprising a spherical core containing the active substance with a smooth surface and a coating on the core, which controls pH-independent release of the active substance. With a pellet of this kind, the release of the active substance may follow a profile with a ...


4
Steven D Walter, Kenneth E Garde, Ronald J Flower: Methods for implementing current delivery profiles used in an iontophoretic system. Drug Delivery Technologies, Mark R Leslie, Kirkpatrick & Lockhart, July 26, 2001: US20010009983-A1

An iontophoretic system is provided, including a patch and a controller. The patch includes a plurality of electrodes electrically connectable to the controller and through which current is applied by the controller to the skin. The controller includes at least one current delivery profile, an input ...


5
Burkhard Schlutermann, Manfred Kohlmeyer: Oral Preparation With Controlled Release. Add Advanced Drug Delivery Technologies, Hedman & Costigan PC, December 17, 2009: US20090311319-A1

Abstract Oral preparation with controlled release A pharmaceutical pellet is provided, comprising a spherical core containing the active substance with a smooth surface and a coating on the core, which controls pH-independent release of the active substance. With a pellet of this kind, the release o ...


6
Burkhard Schlutermann: Pellets containing a pharmaceutical substance, method for the production thereof and use of the same. Add Advanced Drug Delivery Technologies, Hedman & Costigan PC, April 1, 2010: US20100080849-A1

The invention relates to pellets containing a pharmaceutical substance with a breaking strength of more than 0.001 newton, method of production thereof and pharmaceutical preparations based on said pellets.


7
Burkard Schlutermann, Manfred Kohlmeyer: Oral preparation with controlled release. Add Advanced Drug Delivery Technologies, November 10, 2011: US20110274819-A1

A pharmaceutical pellet is disclosed, comprising a spherical core containing active ingredient with a smooth surface and a coating on the core which controls the release of the active ingredient in a pH-independent manner. With such a pellet the release of the active ingredient can follow a profile ...


8
Schluetermann Burkhard, Kohlmeyer Manfred, Van, Hoogevest Peter, Tiemessen Henricus: Peroral therapeutic system comprising glipizide. Add Advanced Drug Delivery Technologies, Schluetermann Burkhard, Kohlmeyer Manfred, Van, Hoogevest Peter, Tiemessen Henricus, SCHREIBER Wolfgang F, December 6, 2001: WO/2001/091716

There is described a therapeutic system for peroral administration, having a compartment, which contains glipizide, swelling agents and, optionally, water-soluble substances for producing an osmotic or swelling pressure.


9
Schluetermann Burkhard, Kohlmeyer Manfred, Van, Hoogevest Peter, Tiemessen Henricus: Oral delivery form comprising glipizide. Add Advanced Drug Delivery Technologies, Schluetermann Burkhard, Kohlmeyer Manfred, Van, Hoogevest Peter, Tiemessen Henricus, SCHREIBER Wolfgang F, December 6, 2001: WO/2001/091717

There is described an oral sustained release composition for glipizide comprising a core, a wall around the core, and a hole through the wall connecting the core with the liquid environment outside of the wall. The core comprises glipizide and customary additives used for preparing tablets. The wall ...


10
Sage Burton H Jr, Bock Carl Randolph: Selected drug delivery profiles using competing ions. Drug Delivery Technologies, SCHRAMM David, July 19, 2001: WO/2001/051120

The present invention relates to a non-invasive method and apparatus for pre selecting the drug delivery profile of a drug by controlling the concentration of ions added to or present in the reservoir containing the drug to be delivered, which ions would compete with the drug ions for the current. T ...